UK trade group slams No­vo, No­var­tis, Pfiz­er and Ot­su­ka for code breach­es

A British watch­dog has crit­i­cized four drug­mak­ers, in­clud­ing No­vo Nordisk, for vi­o­lat­ing the As­so­ci­a­tion of the British Phar­ma­ceu­ti­cal In­dus­try’s code of prac­tice, mark­ing the third …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER